Home › Trial NCT03618810
Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer
- Trial IDNCT03618810
- StatusUnknown
- PhaseN/A
- Study typeObservational
- SponsorZhejiang Cancer Hospital
- Enrollment2000
- Start date2019-01-20
- ConditionsFebrile Neutropenia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.